The therapeutic role of endothelial progenitor cells in Type 1 diabetes mellitus

Regenerative Medicine

Volumn 6, Issue 5, 2011, Pages 599-605

  Grapensparr, Liza ^a   Olerud, Johan ^a   Vasylovska, Svitlana ^a   Carlsson, Per Ola ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

cells; endothelial cells; endothelial progenitor cells; stem cells; Type 1 diabetes

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; COLLAGEN TYPE 4; ENDOTHELIN 1; ERYTHROPOIETIN; GELATINASE B; GLUCOSE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INSULIN; LAMININ; RANTES; SCATTER FACTOR; THROMBOSPONDIN 1; VASCULOTROPIN A;

ANGIOGENESIS; AUTOIMMUNITY; CELL COUNT; CELL CULTURE; CELL DESTRUCTION; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TYPE; DENSITY GRADIENT CENTRIFUGATION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM INJURY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; NEURAL CREST STEM CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE REPAIR;

BLOOD GLUCOSE; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; DIABETES MELLITUS, TYPE 1; ENDOTHELIAL CELLS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELLS;

EID: 80052887365     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.11.45     Document Type: Review

References (72)

1. Richardson SJ, Willcox A, Bone AJ, Morgan NG, Foulis AK. Immunopathology of the human pancreas in Type-I diabetes. Semin. Immunopathol. 33(1), 9-21 (2011).
2. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14(10), 619-633 (1965).
3. Riddle MC. Treatment of diabetes with insulin. From art to science. West J. Med. 138(6), 838-846 (1983). (Pubitemid 13059057)
4. Shapiro A, Lakey J, Ryan E, et al. Islet transplantation in seven patients with Type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343(4), 230-238 (2000). (Pubitemid 30490390)
5. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes 54(7), 2060-2069 (2005). (Pubitemid 40911269)
6. Moberg L, Johansson H, Lukinius A, et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 360(9350), 2039-2045 (2002). (Pubitemid 36026584)
7. Jansson L, Carlsson P. Graft vascular function after transplantation of pancreatic islets. Diabetologia 45(6), 749-763 (2002).
8. Lau J, Carlsson PO. Low revascularization of human islets when experimentally transplanted into the liver. Transplantation 87(3), 322-325 (2009).
9. Olerud J, Johansson M, Lawler J, Welsh N, Carlsson PO. Improved vascular engraftment and graft function after inhibition of the angiostatic factor thrombospondin-1 in mouse pancreatic islets. Diabetes 57(7), 1870-1877 (2008).
10. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302), 964-967 (1997). (Pubitemid 27087709)
11. Hur J, Yoon CH, Kim HS, et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vasc. Biol. 24(2), 288-293 (2004). (Pubitemid 38197580)
12. Rehman J, Li J, Orschell CM, March KL. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107(8), 1164-1169 (2003). (Pubitemid 36297209)
13. Alev C, Ii M, Asahara T. Endothelial progenitor cells: a novel tool for the therapy of ischemic diseases. Antioxid. Redox Signal. 15(4), 949-965 (2011).
14. Yin AH, Miraglia S, Zanjani ED, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90(12), 5002-5012 (1997). (Pubitemid 28007217)
15. Janic B, Guo AM, Iskander AS, Varma NR, Scicli AG, Arbab AS. Human cord blood-derived AC133+ progenitor cells preserve endothelial progenitor characteristics after long term in vitro expansion. PLoS One 5(2), e9173 (2010).
16. Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 95(3), 952-958 (2000). (Pubitemid 30062717)
17. Boyer M, Townsend LE, Vogel LM, et al. Isolation of endothelial cells and their progenitor cells from human peripheral blood. J. Vasc. Surg. 31(1 Pt 1), 181-189 (2000). (Pubitemid 30067315)
18. Casamassimi A, Balestrieri ML, Fiorito C, et al. Comparison between total endothelial progenitor cell isolation versus enriched Cd133+ culture. J. Biochem. 141(4), 503-511 (2007). (Pubitemid 351455307)
19. Khachi S, Zhu Y, Yang GY. Preparation and analysis of endothelial progenitor cells associated with angiogenesis. Methods Mol. Biol. 621, 139-148 (2010).
20. Jianguo W, Tianhang L, Hong Z, et al. Optimization of culture conditions for endothelial progenitor cells from porcine bone marrow in vitro. Cell Prolif. 43(4), 418-426 (2010).
21. Pitchford SC, Furze RC, Jones CP, Wengner AM, Rankin SM. Differential mobilization of subsets of progenitor cells from the bone marrow. Cell Stem Cell 4(1), 62-72 (2009).
22. Heissig B, Hattori K, Dias S, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109(5), 625-637 (2002). (Pubitemid 34628725)
23. Hattori K, Dias S, Heissig B, et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J. Exp. Med. 193(9), 1005-1014 (2001). (Pubitemid 32436194)
24. Heeschen C, Aicher A, Lehmann R, et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102(4), 1340-1346 (2003). (Pubitemid 36988041)
25. Takahashi T, Kalka C, Masuda H, et al. Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5(4), 434-438 (1999). (Pubitemid 29180584)
26. Jujo K, Hamada H, Iwakura A, et al. CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction. Proc. Natl Acad. Sci. USA 107(24), 11008-11013 (2010).
27. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 9(6), 702-712 (2003). (Pubitemid 36749219)
28. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85(3), 221-228 (1999). (Pubitemid 29377293)
29. Zhang Y, Ingram DA, Murphy MP, et al. Release of proinflammatory mediators and expression of proinflammatory adhesion molecules by endothelial progenitor cells. Am. J. Physiol. Heart Circ. Physiol. 296(5), H1675-H1682 (2009).
30. Yoon CH, Hur J, Park KW, et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 112(11), 1618-1627 (2005). (Pubitemid 41324524)
31. Spring H, Schüler T, Arnold B, Hämmerling GJ, Ganss R. Chemokines direct endothelial progenitors into tumor neovessels. Proc. Natl Acad. Sci. USA 102(50), 18111-18116 (2005). (Pubitemid 41798510)
32. Ziegelhoeffer T, Fernandez B, Kostin S, et al. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ. Res. 94(2), 230-238 (2004). (Pubitemid 38197456)
33. Wickersheim A, Kerber M, De Miguel LS, Plate KH, Machein MR. Endothelial progenitor cells do not contribute to tumor endothelium in primary and metastatic tumors. Int. J. Cancer 125(8), 1771-1777 (2009).
34. Siddique A, Shantsila E, Lip GY, Varma C. Endothelial progenitor cells: what use for the cardiologist? J. Angiogenes. Res. 2, 6 (2010).
35. Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJ, Verma S. Endothelial progenitor cells: new hope for a broken heart. Circulation 107(24), 3093-3100 (2003). (Pubitemid 36758985)
36. Bogoslovsky T, Chaudhry A, Latour L, et al. Endothelial progenitor cells correlate with lesion volume and growth in acute stroke. Neurology 75(23), 2059-2062 (2010).
37. Janic B, Arbab AS. The role and therapeutic potential of endothelial progenitor cells in tumor neovascularization. ScientificWorldJournal 10, 1088-1099 (2010).
38. Mund JA, Ingram DA, Yoder MC, Case J. Endothelial progenitor cells and cardiovascular cell-based therapies. Cytotherapy 11(2), 103-113 (2009).
39. Lou J, Triponez F, Oberholzer J, et al. Expression of a-1 proteinase inhibitor in human islet microvascular endothelial cells. Diabetes 48(9), 1773-1778 (1999). (Pubitemid 29415196)
40. Gittes GK. Developmental biology of the pancreas: a comprehensive review. Dev. Biol. 326(1), 4-35 (2009).
41. Johansson M, Mattsson G, Andersson A, Jansson L, Carlsson PO. Islet endothelial cells and pancreatic b-cell proliferation: studies in vitro and during pregnancy in adult rats. Endocrinology 147(5), 2315-2324 (2006).
42. Olerud J, Mokhtari D, Johansson M, et al. Thrombospondin-1: an islet endothelial cell signal of importance for b-cell function. Diabetes 60(7), 1946-1954 (2011).
43. Johansson A, Lau J, Sandberg M, Borg LA, Magnusson PU, Carlsson PO. Endothelial cell signalling supports pancreatic b cell function in the rat. Diabetologia 52(11), 2385-2394 (2009).
44. Nikolova G, Jabs N, Konstantinova I, et al. The vascular basement membrane: a niche for insulin gene expression and b cell proliferation. Dev. Cell 10(3), 397-405 (2006).
45. Akirav EM, Baquero MT, Opare-Addo LW, et al. Glucose and inflammation control islet vascular density and b-cell function in NOD mice: control of islet vasculature and vascular endothelial growth factor by glucose. Diabetes 60(3), 876-883 (2011).
46. Favaro E, Nardo G, Persano L, et al. Hypoxia inducible factor-1a inactivation unveils a link between tumor cell metabolism and hypoxia-induced cell death. Am. J. Pathol. 173(4), 1186-1201 (2008).
47. Mathews V, Hanson PT, Ford E, Fujita J, Polonsky KS, Graubert TA. Recruitment of bone marrow-derived endothelial cells to sites of pancreatic b-cell injury. Diabetes 53(1), 91-98 (2004). (Pubitemid 38044702)
48. Khoo CP, Valorani MG, Brittan M, et al. Characterization of endothelial progenitor cells in the NOD mouse as a source for cell therapies. Diabetes Metab. Res. Rev. 25(1), 89-93 (2009).
49. Contreras JL, Smyth CA, Eckstein C, et al. Peripheral mobilization of recipient bone marrow-derived endothelial progenitor cells enhances pancreatic islet revascularization and engraftment after intraportal transplantation. Surgery 134(2), 390-398 (2003). (Pubitemid 37070366)
50. Olerud J, Kanaykina N, Vasylovska S, et al. Neural crest stem cells increase b cell proliferation and improve islet function in co-transplanted murine pancreatic islets. Diabetologia 52(12), 2594-2601 (2009).
51. Lee RH, Seo MJ, Reger RL, et al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc. Natl Acad. Sci. USA 103(46), 17438-17443 (2006). (Pubitemid 44788987)
52. Madec AM, Mallone R, Afonso G, et al. Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells. Diabetologia 52(7), 1391-1399 (2009).
53. Venneri MA, De Palma M, Ponzoni M, et al. Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. Blood 109(12), 5276-5285 (2007). (Pubitemid 46890548)
54. Hur J, Yang HM, Yoon CH, et al. Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies. Circulation 116(15), 1671-1682 (2007). (Pubitemid 47537841)
55. Bell GI, Broughton HC, Levac KD, Allan DA, Xenocostas A, Hess DA. Transplanted human bone marrow progenitor subtypes stimulate endogenous islet regeneration and revascularization. Stem Cells Dev. DOI:10.1089/scd.2010.0583 (2011) (Epub ahead of print).
56. Luo JZ, Xiong F, Al-Homsi AS, Roy T, Luo LG. Human BM stem cells initiate angiogenesis in human islets in vitro. Bone Marrow Transplant. 46(8), 1128-1137 (2011).
57. Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363(9419), 1439-1441 (2004). (Pubitemid 38586721)
58. Longoni B, Szilagyi E, Quaranta P, et al. Mesenchymal stem cells prevent acute rejection and prolong graft function in pancreatic islet transplantation. Diabetes Technol. Ther. 12(6), 435-446 (2010).
59. Xu YX, Chen L, Wang R, et al. Mesenchymal stem cell therapy for diabetes through paracrine mechanisms. Med. Hypotheses 71(3), 390-393 (2008).
60. Potapova IA, Gaudette GR, Brink PR, et al. Mesenchymal stem cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro. Stem Cells 25(7), 1761-1768 (2007). (Pubitemid 47121855)
61. Park KS, Kim YS, Kim JH, et al. Trophic molecules derived from human mesenchymal stem cells enhance survival, function, and angiogenesis of isolated islets after transplantation. Transplantation 89(5), 509-517 (2010).
62. Johansson U, Rasmusson I, Niclou SP, et al. Formation of composite endothelial cell- mesenchymal stem cell islets: a novel approach to promote islet revascularization. Diabetes 57(9), 2393-2401 (2008).
63. Ianus A, Holz GG, Theise ND, Hussain MA. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J. Clin. Invest. 111(6), 843-850 (2003). (Pubitemid 37074959)
64. Lau J, Mattsson G, Carlsson C, et al. Implantation site-dependent dysfunction of transplanted pancreatic islets. Diabetes 56(6), 1544-1550 (2007). (Pubitemid 46842607)
65. Kidd S, Spaeth E, Dembinski JL, et al. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells 27(10), 2614-2623 (2009).
66. Karnoub AE, Dash AB, Vo AP, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449(7162), 557-563 (2007). (Pubitemid 47525152)
67. Suzuki K, Sun R, Origuchi M, et al. Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization. Mol. Med. 17(7-8), 579-587 (2011).
68. Papaspyridonos M, Lyden D. The role of bone marrow-derived cells in tumor angiogenesis and metastatic progression. Methods Enzymol. 444, 255-269 (2008).
69. Qian BZ, Li J, Zhang H, et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475(7355), 222-225 (2011).
70. Plank JL, Mundell NA, Frist AY, et al. Influence and timing of arrival of murine neural crest on pancreatic b cell development and maturation. Dev. Biol. 349(2), 321-330 (2011).
71. Imai J, Katagiri H, Yamada T, et al. Regulation of pancreatic b cell mass by neuronal signals from the liver. Science 322(5905), 1250-1254 (2008).
72. Eberhard D, Kragl M, Lammert E. Giving and taking: endothelial and b-cells in the islets of Langerhans. Trends Endocrinol. Metab. 21(8), 457-463 (2010).